| Dr Mahbubul B Patwary, MD | |
|
12266 De Paul Dr Ste 315, Bridgeton, MO 63044-2514 | |
| (314) 739-5858 | |
| Not Available |
| Full Name | Dr Mahbubul B Patwary |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 13 Years |
| Location | 12266 De Paul Dr Ste 315, Bridgeton, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801184403 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0204X | Radiology - Vascular & Interventional Radiology | 2017014909 (Missouri) | Secondary |
| 2085R0202X | Radiology - Diagnostic Radiology | 2017014909 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ssm St Joseph Hospital West | Lake saint louis, MO | Hospital |
| Ssm St Joseph Health Center | Saint charles, MO | Hospital |
| Ssm Depaul Health Center | Bridgeton, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Radiologic Imaging Consultants, Llp | 4587652748 | 16 |
| Ssm Medical Group Inc | 6608776299 | 491 |
News Archive
CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company engaged in the development of high-value human therapeutics, today announced its intention during the 2009 fourth quarter to submit a revised protocol for its planned Phase IIb clinical trial for arimoclomol as a treatment for amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease). The decision follows receipt of an anticipated written letter from the U.S.
Yseop, the world-leading AI software company and pioneer in Natural Language Generation (NLG), today announced the launch of Augmented Analyst, a new enterprise-wide NLG automated report generation platform.
While it has been recognised for decades that breastfeeding is better for both mothers and babies, scientists are now suggesting that it also benefits a child's intelligence.
The Food and Drug Administration today announced that it will embark on a thorough scientific assessment of the health significance of very low levels of furan - a chemical that is produced through the heating process - in certain foods. FDA has initiated this process through a notice on display today at the Office of the Federal Register.
› Verified 5 days ago
| Entity Name | Radiologic Imaging Consultants, Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871689505 PECOS PAC ID: 4587652748 Enrollment ID: O20040505000834 |
News Archive
CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company engaged in the development of high-value human therapeutics, today announced its intention during the 2009 fourth quarter to submit a revised protocol for its planned Phase IIb clinical trial for arimoclomol as a treatment for amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease). The decision follows receipt of an anticipated written letter from the U.S.
Yseop, the world-leading AI software company and pioneer in Natural Language Generation (NLG), today announced the launch of Augmented Analyst, a new enterprise-wide NLG automated report generation platform.
While it has been recognised for decades that breastfeeding is better for both mothers and babies, scientists are now suggesting that it also benefits a child's intelligence.
The Food and Drug Administration today announced that it will embark on a thorough scientific assessment of the health significance of very low levels of furan - a chemical that is produced through the heating process - in certain foods. FDA has initiated this process through a notice on display today at the Office of the Federal Register.
› Verified 5 days ago
| Entity Name | Ssm Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700966207 PECOS PAC ID: 6608776299 Enrollment ID: O20040729001034 |
News Archive
CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company engaged in the development of high-value human therapeutics, today announced its intention during the 2009 fourth quarter to submit a revised protocol for its planned Phase IIb clinical trial for arimoclomol as a treatment for amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease). The decision follows receipt of an anticipated written letter from the U.S.
Yseop, the world-leading AI software company and pioneer in Natural Language Generation (NLG), today announced the launch of Augmented Analyst, a new enterprise-wide NLG automated report generation platform.
While it has been recognised for decades that breastfeeding is better for both mothers and babies, scientists are now suggesting that it also benefits a child's intelligence.
The Food and Drug Administration today announced that it will embark on a thorough scientific assessment of the health significance of very low levels of furan - a chemical that is produced through the heating process - in certain foods. FDA has initiated this process through a notice on display today at the Office of the Federal Register.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mahbubul B Patwary, MD 220 Compass Point Drive, St Charles, MO 63301 Ph: (636) 947-4480 | Dr Mahbubul B Patwary, MD 12266 De Paul Dr Ste 315, Bridgeton, MO 63044-2514 Ph: (314) 739-5858 |
News Archive
CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company engaged in the development of high-value human therapeutics, today announced its intention during the 2009 fourth quarter to submit a revised protocol for its planned Phase IIb clinical trial for arimoclomol as a treatment for amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease). The decision follows receipt of an anticipated written letter from the U.S.
Yseop, the world-leading AI software company and pioneer in Natural Language Generation (NLG), today announced the launch of Augmented Analyst, a new enterprise-wide NLG automated report generation platform.
While it has been recognised for decades that breastfeeding is better for both mothers and babies, scientists are now suggesting that it also benefits a child's intelligence.
The Food and Drug Administration today announced that it will embark on a thorough scientific assessment of the health significance of very low levels of furan - a chemical that is produced through the heating process - in certain foods. FDA has initiated this process through a notice on display today at the Office of the Federal Register.
› Verified 5 days ago
Dr. Lewis C Halverson, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 12266 De Paul Dr Ste 315, Bridgeton, MO 63044 Phone: 314-739-5858 | |
Dr. Clelland James-henry Chatman, M.D. Radiology Medicare: May Accept Medicare Assignments Practice Location: 12303 De Paul Dr, Bridgeton, MO 63044 Phone: 314-770-9393 Fax: 314-770-9997 | |
Thomas P Bocchini, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 12266 De Paul Dr Ste 305, Bridgeton, MO 63044 Phone: 314-770-0991 | |
Andre Strzembosz, MD Radiology Medicare: May Accept Medicare Assignments Practice Location: 12303 De Paul Dr, Depaul Health Center, Bridgeton, MO 63044 Phone: 314-344-6350 | |
Larry Paskar, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 12303 De Paul Dr, Depaul Health Center, Bridgeton, MO 63044 Phone: 314-344-6350 | |
Edwin C Ernst Iii, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 12303 Depaul Dr, Depaul Health Center, Bridgeton, MO 63044 Phone: 314-344-6350 | |
Megan M Gau, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 12303 Depaul Dr, Depaul Health Center, Bridgeton, MO 63044 Phone: 314-344-6000 |